S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Anavex Life Sciences (AVXL) SEC Filings & 10K Form

$3.80
-0.27 (-6.63%)
(As of 04/18/2024 ET)

Recent Anavex Life Sciences SEC Filings

DateFilerForm TypeView
04/01/2024
5:00 PM
Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
7:34 AM
Anavex Life Sciences (Subject)
MISSLING CHRISTOPHER U (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/23/2024
5:03 AM
Anavex Life Sciences (Issuer)
Skarpelos Athanasios (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
5:03 AM
Anavex Life Sciences (Issuer)
Ma Jiong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
5:04 AM
Anavex Life Sciences (Issuer)
Velden Claus Vander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
5:04 AM
Anavex Life Sciences (Issuer)
Thomas Steffen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
5:05 AM
Anavex Life Sciences (Issuer)
Donhauser Peter D.O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
4:01 PM
Anavex Life Sciences (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
01/22/2024
10:34 AM
Anavex Life Sciences (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/12/2024
7:00 PM
Anavex Life Sciences (Issuer)
Boenisch Sandra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2024
7:00 PM
Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2023
3:30 PM
Anavex Life Sciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
06/30/2023
7:00 PM
Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2023
11:11 AM
Anavex Life Sciences (Subject)
MISSLING CHRISTOPHER U (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/24/2023
3:30 PM
Anavex Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2023
3:31 PM
Anavex Life Sciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:AVXL) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners